Hemagen Diagnostics (Hemagen Diagnostics) Days Payable : 71.04 (As of Sep. 2012)

View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Days Payable?

Hemagen Diagnostics's average Accounts Payable for the three months ended in Sep. 2012 was $0.37 Mil. Hemagen Diagnostics's Cost of Goods Sold for the three months ended in Sep. 2012 was $0.47 Mil. Hence, Hemagen Diagnostics's Days Payable for the three months ended in Sep. 2012 was 71.04.

The historical rank and industry rank for Hemagen Diagnostics's Days Payable or its related term are showing as below:

HMGN's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.28
* Ranked among companies with meaningful Days Payable only.

Hemagen Diagnostics's Days Payable increased from Sep. 2011 (55.85) to Sep. 2012 (71.04). It may suggest that Hemagen Diagnostics delayed paying its suppliers.

Hemagen Diagnostics Days Payable Historical Data

The historical data trend for Hemagen Diagnostics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Days Payable Chart

Hemagen Diagnostics Annual Data

Trend

Sep03

Sep04

Sep05

Sep06

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Days Payable

Get a 7-Day Free Trial

80.54

70.67

55.37

41.55

58.90

Hemagen Diagnostics Quarterly Data
	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12
Days Payable	Get a 7-Day Free Trial															55.85	54.10	-	-	71.04

Competitive Comparison of Hemagen Diagnostics's Days Payable

For the Biotechnology subindustry, Hemagen Diagnostics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemagen Diagnostics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's Days Payable distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's Days Payable falls into.

Hemagen Diagnostics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Hemagen Diagnostics's Days Payable for the fiscal year that ended in Sep. 2012 is calculated as

	Days Payable (A: Sep. 2012 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Sep. 2011 )	+	Accounts Payable (A: Sep. 2012 ))	/	count )	/	Cost of Goods Sold (A: Sep. 2012 )	*	Days in Period
=	( (0.415	+	0.369)	/	2 )	/	2.429	*	365
=	0.392					/	2.429	*	365
=	58.90

Hemagen Diagnostics's Days Payable for the quarter that ended in Sep. 2012 is calculated as:

	Days Payable (Q: Sep. 2012 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2012 )	+	Accounts Payable (Q: Sep. 2012 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2012 )	*	Days in Period
=	( (0	+	0.369)	/	1 )	/	0.474	*	365 / 4
=	0.369					/	0.474	*	365 / 4
=	71.04

Hemagen Diagnostics Days Payable Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

9033 Red Branch Road, Columbia, MD, USA, 21045

Website

http://www.hemagen.com

Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.

Executives

Howard F Curd

director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines